Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2021

Nov 10, 2021

33899_dirs_2021-11-10_fcc13015-982f-45e0-9279-13c9319e9e73.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2021-11-08

Reporting Person: BROWN JEFFREY J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-08 Common Stock P 199.898 $218.49 Acquired 30957.146 Indirect
2021-11-08 Common Stock P 160 $224.96 Acquired 31117.146 Indirect
2021-11-08 Common Stock P 200 $226.68 Acquired 31317.146 Indirect
2021-11-08 Common Stock P 200 $227.78 Acquired 31517.146 Indirect
2021-11-08 Common Stock P 290 $229.91 Acquired 31807.146 Indirect
2021-11-08 Common Stock P 150 $231.65 Acquired 31957.146 Indirect
2021-11-08 Common Stock P 807 $232.55 Acquired 32764.146 Indirect
2021-11-08 Common Stock P 593 $233.68 Acquired 33357.146 Indirect
2021-11-08 Common Stock P 1000 $234.52 Acquired 34357.146 Indirect
2021-11-08 Common Stock P 600 $235.28 Acquired 34957.146 Indirect

Footnotes

F1: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.

F2: This transaction was executed in multiple trades at prices ranging from $224.67 USD to $225.45 USD; the price reported above reflects the weighted average sale price.

F3: This transaction was executed in multiple trades at prices ranging from $226.51 USD to $226.85 USD; the price reported above reflects the weighted average sale price.

F4: This transaction was executed in multiple trades at prices ranging from $227.61 USD to $227.95 USD; the price reported above reflects the weighted average sale price.

F5: This transaction was executed in multiple trades at prices ranging from $229.75 USD to $230.13 USD; the price reported above reflects the weighted average sale price.

F6: This transaction was executed in multiple trades at prices ranging from $231.57 USD to $231.82 USD; the price reported above reflects the weighted average sale price.

F7: This transaction was executed in multiple trades at prices ranging from $232.00 USD to $232.99 USD; the price reported above reflects the weighted average sale price.

F8: This transaction was executed in multiple trades at prices ranging from $233.12 USD to $233.96 USD; the price reported above reflects the weighted average sale price.

F9: This transaction was executed in multiple trades at prices ranging from $234.11 USD to $234.99 USD; the price reported above reflects the weighted average sale price.

F10: This transaction was executed in multiple trades at prices ranging from $235.00 USD to $235.71 USD; the price reported above reflects the weighted average sale price.

F11: These shares are directly owned by Brown Equity Partners, LLC, for which the reporting person is the managing member.